| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/20/2010 | EP1487493B1 Conjugates of cytotoxic agents and biologically active peptides |
| 01/20/2010 | EP1379272B1 Monoclonal antibodies directed against molecular mimetics of meningococcal b epitopes |
| 01/20/2010 | EP0917538B1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications |
| 01/20/2010 | CN101631563A Lyophilized preparation comprising influenza vaccine, and method for preparation thereof |
| 01/20/2010 | CN101628933A HIV peptides from tat, rev and wef conserved and their application as e.g. vaccine components |
| 01/20/2010 | CN101628114A Broad spectrum anti-tumor composite vaccine |
| 01/20/2010 | CN101628111A TACI-immunoglobulin fusion proteins |
| 01/20/2010 | CN101628005A Use of beta-glucans against biological warfare weapons and pathogens including anthrax |
| 01/20/2010 | CN100582244C Methods of producing influenza vaccine compositions |
| 01/20/2010 | CN100582122C O-type foot-and-mouth disease virus multi-epitope mucous membrane immunization vaccine and use |
| 01/20/2010 | CN100581621C CNS chloride modulation and uses thereof |
| 01/20/2010 | CN100581585C Novel remedies for cancer |
| 01/19/2010 | US7649085 Saquinavir conjugates and antibodies useful in immunoassay |
| 01/19/2010 | US7648971 Thrombopoietin mimetics |
| 01/19/2010 | US7648962 which retain activity for stimulating cyclic guanosine monophosphate production and binding to natriuretic peptide receptor type A; improved bioavailability and half-life in circulation; for treatment of congestive heart failure |
| 01/19/2010 | US7648830 Using fibrinogen immobilized support to isolate lysostaphin and methicillin resistant staphloccus; high throughput assay |
| 01/19/2010 | US7648827 Use of eukaryotic genes affecting cell cycle control or cell cycle progression for diagnosis and treatment of proliferative diseases |
| 01/19/2010 | US7648721 Whey protein and hydrolysed casein protein; reduced allergies |
| 01/19/2010 | US7648709 a vccine formulation for diminishing type I anaphylactic hypersensitivity to domestic mites inducing a Th-1 type immune response to such mites, containing a proteoliposome from the outer membrane of Neisseria mentingitidis; an allergen from domestic mites; and aluminum hydroxide as a depot adjuvant |
| 01/19/2010 | US7648708 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 01/19/2010 | US7648707 Compositions and methods for treatment of microbial infections |
| 01/19/2010 | US7648706 West nile DNA vaccine |
| 01/19/2010 | US7648705 Methods for prevention or amelioration of West Nile encephalitis using a West Nile DNA vaccine |
| 01/19/2010 | US7648704 Diagnosis and treatment of human dormancy syndrome |
| 01/19/2010 | US7648703 Combination of anti-EP-CAM antibody with a chemotherapeutic agent |
| 01/19/2010 | US7648702 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine. |
| 01/19/2010 | US7648701 Peptide composition as immunogen for the treatment of allergy |
| 01/19/2010 | US7648698 Vaccine for veterinary and human medicine prophylaxis and therapy |
| 01/19/2010 | CA2373255C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 01/19/2010 | CA2301891C Rna respiratory synctial virus vaccines |
| 01/19/2010 | CA2123492C Lymphoid antigen cd30 |
| 01/14/2010 | WO2010006326A2 Methods and compositions for spore-based vaccines |
| 01/14/2010 | WO2010006315A2 Alpha-galactosyl ceramide analogs and their use as immunotherapies, adjuvants, and intiviral, antibacterial, and anticancer agents |
| 01/14/2010 | WO2010006296A2 New avian bornavirus |
| 01/14/2010 | WO2010006214A1 Fgf-21 neutralizing antibodies and their uses |
| 01/14/2010 | WO2010006168A2 Methods of treating cancer using and agent that modulates activity of the calcitonin-gene related peptide ("cgrp") receptor |
| 01/14/2010 | WO2010006144A2 Influenza hemagglutinin and neuraminidase variants |
| 01/14/2010 | WO2010006136A2 Adenovirus targeting |
| 01/14/2010 | WO2010006059A1 Prostaglandin e2 binding proteins and uses thereof |
| 01/14/2010 | WO2010005868A2 A vaccine for porcine post-weaning diarrhea caused by enterotoxigenic escherichia coli |
| 01/14/2010 | WO2010005858A1 Vaccine for the treatment of alzheimer's disease |
| 01/14/2010 | WO2010005598A1 Globo h and related anti-cancer vaccines with novel glycolipid adjuvants |
| 01/14/2010 | WO2010005575A2 Nanotube-reinforced balloons for delivering therapeutic agents within or beyond the wall of blood vessels, and methods of making and using same |
| 01/14/2010 | WO2010005570A2 Compositions comprising antibodies to lingo or fragments thereof |
| 01/14/2010 | WO2010005567A2 Notch1 receptor binding agents and methods of use thereof |
| 01/14/2010 | WO2010005566A2 Notch-binding agents and antagonists and methods of use thereof |
| 01/14/2010 | WO2010005513A2 Crystal structure of staphylococcus aureus clumping factor a in complex with fibrinogen derived peptide and uses thereof |
| 01/14/2010 | WO2010005474A1 Recombinant modified vaccinia virus ankara (mva) expressing chlamydia polypeptide antigens |
| 01/14/2010 | WO2010005389A1 Oxidized ldl specific antibody-fusion and conjugated proteins |
| 01/14/2010 | WO2010005069A1 Immunity-inducing agent and method for detection of cancer |
| 01/14/2010 | WO2010005068A1 Pharmaceutical composition for treatment and prevention of cancer |
| 01/14/2010 | WO2010004568A1 Device, method and kit for in vivo detection of a biomarker |
| 01/14/2010 | WO2010004432A1 Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins |
| 01/14/2010 | WO2010004292A1 Chimaeric peptide |
| 01/14/2010 | WO2010004204A2 Fgf-r4 receptor-specific antagonists |
| 01/14/2010 | WO2010004043A1 Recombinant adenoviral feline leukemia virus vaccine and use thereof |
| 01/14/2010 | WO2010003992A1 Combination of a c-met antagonist and an aminoheteroaryl compound for the treatment of cancer |
| 01/14/2010 | WO2010003977A1 Therapeutic use of specific ligand in msrv associated diseases |
| 01/14/2010 | WO2010003670A1 Stabilizer and vaccine composition comprising one or more live attenuated flaviviruses |
| 01/14/2010 | WO2010003635A1 Modulation of the immune response by means of the nkp65 receptor and the clec2a ligand thereof |
| 01/14/2010 | WO2010003268A2 Methods and compositions for enhanced delivery of macromolecules |
| 01/14/2010 | WO2010003235A1 Soluble recombinant influenza antigens |
| 01/14/2010 | WO2010003225A1 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 01/14/2010 | WO2010003219A1 Compositions comprising salmonella porins and uses thereof as adjuvants and vaccines |
| 01/14/2010 | WO2009143167A3 Dual delivery system for heterologous antigens |
| 01/14/2010 | WO2009141434A4 Expression vector encoding alphavirus replicase and the use thereof as immunological adjuvant |
| 01/14/2010 | WO2009140754A8 An anti-cancer cytotoxic monoclonal antibody |
| 01/14/2010 | WO2009134389A9 An anti-cd137 antibody as an agent in the treatment of inflammatory conditions |
| 01/14/2010 | WO2009132050A3 Auris formulations for treating otic diseases and conditions |
| 01/14/2010 | WO2009130575A3 Isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen, conjugates and uses thereof |
| 01/14/2010 | WO2009124252A3 Methods and compositions for the treatment of rheumatoid arthritis and other inflammatory diseases |
| 01/14/2010 | WO2009117030A3 Improved compositions for the prevention and treatment of smallpox |
| 01/14/2010 | WO2009108235A3 Compositions and methods for modulating immune responses to nucleic acids |
| 01/14/2010 | WO2009104100A3 Antibody combinations, and methods of making and using same |
| 01/14/2010 | WO2009103969A8 Synthetic scfv analogue to the 6313/g2 (anti angiotensin ii type 1 receptor) monoclonal antibody variable regions |
| 01/14/2010 | WO2009094273A3 Compositions and methods for adoptive and active immunotherapy |
| 01/14/2010 | WO2009073139A3 Combined treatment with an egfr kinase inhibitor and an inhibitor of c-kit |
| 01/14/2010 | WO2009052431A3 Cd19 binding agents and uses thereof |
| 01/14/2010 | WO2008150969A9 Electroporation of mycobacterium and overexpression of antigens in mycobacteria |
| 01/14/2010 | WO2008106662A3 Nitrilases, nucleic acids encoding them and methods for making and using them |
| 01/14/2010 | WO2006110413A9 Haemophilus influenzae type b |
| 01/14/2010 | WO2006014505A9 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/14/2010 | WO2003064603A9 Nucleic acid molecule encoding iwu-1 |
| 01/14/2010 | US20100011456 Nucleic Acids and Proteins and Methods for Making and Using Them |
| 01/14/2010 | US20100010470 Nanotube-Reinforced Balloons For Delivering Therapeutic Agents Within Or Beyond The Wall of Blood Vessels, And Methods Of Making And Using Same |
| 01/14/2010 | US20100010211 Vaccine |
| 01/14/2010 | US20100010210 Vaccine |
| 01/14/2010 | US20100010203 Anti-hydroxylase antibodies and uses thereof |
| 01/14/2010 | US20100010195 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 01/14/2010 | US20100010193 Immunogenic complexes and methods relating thereto |
| 01/14/2010 | US20100010075 COMPOUNDS FOR ELICITING OR ENHANCING IMMUNE REACTIVITY TO HER-2/neu PROTEIN FOR PREVENTION OR TREATMENT OF MALIGNANCIES IN WHICH THE HER-2/neu ONCOGENE IS ASSOCIATED |
| 01/14/2010 | US20100009913 Uses for Yerba Santa |
| 01/14/2010 | US20100009439 ANTI-IGF-I RECEPTOR ANTIBODIES, DNAs, VECTORS, HOST CELLS AND GENETIC CONSTRUCTS |
| 01/14/2010 | US20100009438 Dendritic cell potentiation |
| 01/14/2010 | US20100009437 Isolated proteins MAGE-4 and MAGE-41 |
| 01/14/2010 | US20100009406 Gene sequence coding formyl peptide receptor binding protein; diagnosing cancer, wound bone healing, obesity, acute heart failure, hypotension, hypertension, urinary retention, osteoporosis, restenosis, atherosclerosis, thrombosis, cardiovascular, autoimmune and nervous system disorders |
| 01/14/2010 | US20100008994 Electrospun structures and methods for forming and using same |
| 01/14/2010 | US20100008980 Use of MAGE A3-Protein D Fusion Antigen in Immunotherapy Combined with Surgery, Chemotherapy or Radiotherapy for the Treatment of Cancer |
| 01/14/2010 | US20100008975 Predicting response to a HER inhibitor |
| 01/14/2010 | US20100008973 Compositions And Methods For Wound Healing |